Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Chemours Co    CC

CHEMOURS CO (CC)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 04/19 10:03:19 pm
51.92 USD   -1.33%
04/19GLOBAL HFC REFR : 9strategy.biz added a depth and professional marke..
AQ
04/17CHEMOURS : County chastised for lack of communication
AQ
04/17CHEMOURS : Finding GenX
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies

David Meurisse

Contributor / Partner
share with twitter share with LinkedIn share with facebook
share via e-mail

There is still some upside potential

Strategy published on 04/13/2018 | 14:23
long trade
Live
Entry price : 50.95$ | Target : 56.9$ | Stop-loss : 47.4$ | Potential : 11.68%
The current trading zone is interesting to the point that investors should pay attention to the stock and anticipate a return of the underlying upward trend.
Investors have an opportunity to buy the stock and target the $ 56.9.
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
  • Chemours Co accounts for 5.18 % of our USA Portfolio. A trade is currently open since 02/21/2018 with a purchase price of $ 50.23. Discover the other 19 stocks of the USA portfolio managed by the 4-traders portfolio management team.

Strengths
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Its low valuation, with P/E ratio at 9.26 and 8.34 for the ongoing fiscal year and 2019 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • Sales forecast by analysts have been recently revised upwards.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
  • For the past twelve months, EPS forecast has been revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 46.08 USD

Weaknesses
  • The company's earnings releases usually do not meet expectations.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Subsector Commodity Chemicals - NEC
1st jan.Capitalisation (M$)Investor Rating
CHEMOURS CO5.11%9 550
SAUDI BASIC INDUSTRIES CORP..--.--%96 810
AIR LIQUIDE-1.95%54 625
SHIN-ETSU CHEMICAL CO LTD-5.84%44 625
PRAXAIR0.16%44 004
LYONDELLBASELL INDUSTRIES-1.31%42 859
NAN YA PLASTICS CORP--.--%22 412
GIVAUDAN-2.04%21 019
ASAHI KASEI CORP1.75%19 505
PETRONAS CHEMICALS GROUP BH..--.--%17 387
SAUDI ARABIAN MINING COMPAN..--.--%16 890
Autres valeurs du secteur
share with twitter share with LinkedIn share with facebook
share via e-mail
Recevoir les alertes

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2018 6 955 M
EBIT 2018 1 523 M
Net income 2018 1 037 M
Debt 2018 2 323 M
Yield 2018 0,19%
P/E ratio 2018 9,50
P/E ratio 2019 8,56
EV / Sales 2018 1,71x
EV / Sales 2019 1,53x
Capitalization 9 550 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart CHEMOURS CO
Duration : Period : Day
Chemours Co Technical Analysis Chart | CC | US1638511089 | 4-Traders
Duration : Period : Week
Chemours Co Technical Analysis Chart | CC | US1638511089 | 4-Traders